Etiology and management of sustained ventricular tachycardia

American Journal of Cardiovascular Drugs

Volumn 1, Issue 3, 2001, Pages 179-192

  Talwar, K K ^a   Naik, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CATHETER ABLATION; DEFIBRILLATOR; DRUG COMBINATION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE TACHYCARDIA; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CATHETER ABLATION; DEFIBRILLATORS, IMPLANTABLE; DRUG THERAPY, COMBINATION; HUMANS; MYOCARDIAL REVASCULARIZATION; TACHYCARDIA, VENTRICULAR;

EID: 2442489799     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/00129784-200101030-00004     Document Type: Review

References (119)

1. Lown B, Graboys TB. Management of patients with malignant ventricular arrhythmias. Am J Cardiol 1977; 39: 910-8
2. Wellens HJJ, Duren DR, Lie KI. Observations on mechanisms of ventricular tachycardia in man. Circulation 1976; 54: 237-51
3. Josephson ME, Horowitz LN, Farshidi A, et al.. Recurrent sustained ventricular tachycardia: I. Mechanisms. Circulation 1978; 57: 431-40
4. Cassidy DM, Vassallo JA, Marchlinski FE, et al. Endocardial mapping in humans with normal left ventricles: activation patterns and characteristics of electrograms. Circulation 1984; 70: 37-42
5. De Bakker J, van Capelle F, Janse MJ, et al. Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease. Electrophysiologic and anatomic correlation. Circulation 1988; 77: 589-606
6. Waldo AL, Henthorn RW, Plumb VJ, et al. Demonstration of the mechanism of transient entrainment and interruption of ventricular tachycardia with rapid atrial pacing. J Am Coll Cardiol 1984; 3: 422-30
7. Anderson KD, Swerdlow CD, Mason JW. Entrainment of ventricular tachycardia. Am J Cardiol 1984; 53: 335-40
8. Mason JW, Stinson EB, Oyer PE, et al. The mechanisms of ventricular tachycardia in humans determined by intraoperative recording of the electrical activation sequence. Int J Cardiol 1985; 8: 163-75
9. Downar E, Harris L, Mickleborough LL, et al. Endocardial mapping of ventricular tachycardia in the intact human ventricle. Evidence of reentrant mechanisms. J Am Coll Cardiol 1988; 11: 783-91
10. Stevenson WG, Khan H, Sager P, et al. Identification of reentry circuit sites during catheter mapping and radiofrequency ablation of ventricular tachycardia late after myocardial infarction. Circulation 1993; 88: 1647-70
11. Poll DS, Marchlinski FE, Buxton AE, et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58: 992-7
12. Gomes JA, Winters SL, Stewart D, et al. A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and holter monitoring. J Am Coll Cardiol 1987; 10: 349-57
13. El-Sherif N, Denes P, Katz R, et al., for the Cardiac Arrhythmia Suppression Trial/ Signal-Averaged Electrocardiogram (CAST/SAECG) substudy investigators. Definition of the best prediction criteria of the time domain signal-averaged electrocardiogram for serious arrhythmic events in the postinfarction period. J Am Coll Cardiol 1995; 25: 908-14
14. Ikeda T, Sakata T, Takami M, et al. Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. J Am Coll Cardiol 2000; 35: 722-30
15. Hohnloser S, Klingenheben T, Li Y, et al. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD patients: prospective comparison with conventional risk markers. J Cardiovasc Electrophysiol 1998; 9: 1258-68
16. Malik M, Camm AJ, Janse MJ, et al., on behalf of the EMIAT Investigators. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263-75
17. Winkle RA. Ambulatory electrcardiology and the diagnosis, evaluation, and treatment of chronic ventricular arrhythmias. Prog Cardiovasc Dis 1980; 23: 99-128
18. Janse MJ, Kuber AG. Electrophysiological changes and ventricular arrhythmias in the early phase of myocardial ischaemia. Circ Res 1981; 49: 1069-81
19. Corr PB, Gross RW, Sobel BE. Ampipathic metabolites and membrane dysfunction in ischemic myocyte. Circ Res 1984; 55: 135-54
20. Blanck Z, Dhala A, Deshpande S, et al. Bundle branch reentrant ventricular tachycardia: a cummulative experience in 48 patients. J Cardiovasc Electrophysiol 1993; 4: 253-62
21. Brembilla-Perrot B, Donetti J, Terrier de la Chaise A, et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991; 121: 1124-31
22. Alfonso F, Frenneaux MP, McKenna WJ. Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with a left ventricular apical aneurysm. Br Heart J 1989; 61: 178-81
23. McKenna WJ, Thiene G, Nava A, et al., on behalf of the Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, supported by the Schoepfer Association. Diagnosis of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Br Heart J 1994; 71: 215-8
24. Naccarella F, Naccarelli G, Fattori R, et al. Arrhythmogenic right ventricular dysplasia: current opinion on diagnosis and therapeutic aspects. Curr Opin Cardiol 2001; 16: 8-16
25. Burke AP, Farb A, Tashko G, et al. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? Circulation 1998; 97: 1571-80
26. Horimoto M, Akino M, Takinata T, et al. Evolution of left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Cardiology 2000; 93: 197-200
27. Yoshioka N, Tsuchihashi K, Yuda S, et al. Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and in their pedigrees. Am J Cardiol 2000; 85: 885-9
28. Wichter T, Borggrefe M, Haverkamp W, et al. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and nonindicble ventricular tachycardia. Circulation 1992; 86: 29-37
29. Peters S, Peters H, Thierfelder L. Risk stratification of sudden cardiac death and malignant ventricular arrhythmias in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy. Int J Cardiol 1999; 71: 243-50
30. Gatzoulis MA, Balaji S, Webber SA. Risk factors for arrhythmias and sudden cardiac death late after repair of tetralogy of Fallot. Lancet 2000; 356: 975-81
31. Lucron H, Marcon F, Bosser G, et al. Induction of sustained ventricular tachycardia after surgical repair of tetralogy of Fallot. Am J Cardiol 1999; 83: 1369-73
32. Saxena A, Talwar KK, Shrivastava S, et al. Late rhythm abnormalities after surgical repair of tetralogy of Fallot: non invasive and invasive evaluation. Ind Heart J 1995; 47: 223-6
33. Touboul P, Kirkorian G, Attalah G, et al. Bundle branch reentry: a possible mechanism of ventricular tachycardia. Circulation 1983; 67: 674-80
34. Narsimhan C, Jazayeri MR, Sra J, et al. Ventricular tachycardia in valvular heart disease: facilitation of sustained bundle-branch reentry by valve surgery. Circulation 1997; 96: 4307-13
35. Sekiguchi M, Nishizawa M, Numoda S, et al. Endomyocardial biopsy approach in cases with ventricular arrhythmias. Postgrad Med J 1992; 68 Suppl. 1: S40-3
36. Talwar KK, Garg A, Chopra P, et al. Study of myocardial morphology in patients with complex ventricular arrhythmias and suspected dilated cardiomyopathy using endomyocardial biopsy. Cardiovasc World Report 1989; 2: 76-9
37. Vignola PA, Aonuma K, Swaye PS, et al. Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression. J Am Coll Cardiol 1984; 4: 812-9
38. Akhtar M, Damato AN, Batsford WP, et al. Demonstration of reentry within the His-Purkinje system in man. Circulation 1974; 50: 1150-62
39. Caceres J, Jazayerie M, Mc Kinnie J, et al. Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 1988; 79: 256-70
40. Buxton AE, Waxman HL, Marchlienski FE, et al. Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation 1983; 68: 917-27
41. Lerman BB, Stein KM, Markowitz SM, et al. Ventricular arrhythmias in normal hearts. Cardiol Clin 2000; 18 (2): 265-91
42. Lerman BB, Stein K, Engelstein ED, et al. Mechanism of repetitive monomorphic ventricular tachycardia. Circulation 1995; 92: 421-9
43. Lerman BB, Stein KM, Markowitz SM. Mechanisms of idiopathic left ventricular tachycardia. J Cardiovasc Electrophysiol 1997; 8: 571-83
44. Zipes DP, Foster PR, Troup PJ, et al. Atrial induction of ventricular tachycardia: recentry versus triggered activity. Am J Cardiol 1979; 44 (1): 1-8
45. Green LS, Lux RL, Ershler PR, et al. Resolution of pace mapping stimulus site separation using body surface potentials. Circulation 1994; 90: 462-8
46. Singh B, Kaul U, Talwar KK, et al. Reversibility of "tachycardia induced cardiomyopathy" following the cure of idiopathic ventricular tachycardia using radiofrequency energy. Pacing Clin Electrophysiol 1996; 19: 1391-2
47. Thakur RK, Klein GJ, Sivaram CA, et al. Anatomic substrate for idiopathic left ventricular tachycardia. Circulation 1996; 93: 497-501
48. Lin FC, Wen MS, Wang CC, et al. Left ventricular fibromuscular band is not a specific substrate for idiopathic left ventricular tachycardia. Circulation 1996; 93: 525-8
49. Lerman BB. Response of non-reentrant catecholamine mediated ventricular tachycardia to endogenous adenosine and acetylcholine: evidence for myocardial receptor mediated effects. Circulation 1993; 87: 382-90
50. Dessertenne FF. La tachycardie ventriculaire a deux foyers opposes variables. Arch Mal Coeur Vaiss 1966; 59: 263
51. Viskin S. Long QT syndromes and torsade de pointes. Lancet 1999; 354: 1625-33
52. Chiang CE, Roden DM. The long QT syndromes: genetic basis and clinical implications. J Am Coll Cardiol 2000; 36: 1-12
53. Tanaka T, Nagai R, Tomoike H, et al. Four novel kvLQT1 and four novel HERG mutations in familial long QT syndrome. Circulation 1997; 95: 565-7
54. Keating M, Atkinson D, Dunn C, et al. Linkage of a cardiac arrhythmia, the long QT syndrome and the Harvey ras-1 gene. Science 1991; 252: 704-6
55. Jiang C, Atkinson D, Towbin JA, et al. Two long QT syndrome loci map to chromosomes 3 and 7 with evidence of further heterogeneity. Nat Genet 1994; 8: 141-7
56. Wang Q, Shen J, Splanski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805-11
57. Schott JJ, Charpentier F, Pettier S, et al. Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am J Hum Genet 1995; 57: 1114-22
58. Abbott KW, Sesti F, Splawski I, et al. MiRP1 forms Ikr, potassium channels with HERG and is associated with cardiac arrhythmias. Cell 1999; 97: 175-87
59. Kothari SS, Talwar KK, Venugopal P. Septal course of the left main coronary artery from the right coronary sinus and ventricular tachycardia. Int J Cardiol 1998; 66: 207-9
60. Cheitlin MD, De Castro CM, McAllister HA. Sudden death as a complication of anomalous left coronary from anterior sinus of Valsalva: a not-so-minor congenital anomaly. Circulation 1974; 50: 780-7
61. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encanide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12
62. Hohnloser SH, Raeder EA, Podrid PJ, et al. Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular arrhythmias. Am Heart J 1987; 114: 1-7
63. Lown B. Management of patients at high risk of sudden death. Am Heart J 1982; 103: 689-97
64. Mason JW, Winkle RA. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic therapy for recurrent ventricular tachycardia. Circulation 1978; 58: 971-85
65. Mason JW, Winkle RA. Accuracy of the ventricular tachycardia induction study for predicting long-term efficacy and inefficacy of antiarrhythmic drugs. N Engl J Med 1980; 303: 1073-7
66. Mason JW, for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of electrophysiologic testing with holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993; 329: 445-51
67. Mason JW, for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993; 329: 52-8
68. Julian DG, Camm AJ, Frangin MJ, et al., for the European Myocardial Infarct Amiodarone Trial Investigators. Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997; 349: 647-74
69. Cairns JA, Conrolly SJ, Roberts R, et al., for the Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997; 349: 675-82
70. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarctionand in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 1997 Nov 15; 350 (9089): 1417-24
71. Nasir N, Swarna US, Boachene KA, et al. Therapy of sustained ventricular arrhythmias with amiodarone: prediction of efficacy with serial electrophysisolgic studies. J. Cardiovasc Pharmacol Ther 1996; 1: 123-33
72. Maury P, Zimmermann M, Metzger J, et al. Amiodarone therapy for sustained ventricular tachycardia after myocardial infarction: long-term follow-up, risk assessment and predictive value of programmed ventricular stimulation. Int J Cardiol 2000; 76: 199-210
73. Sun W, Sarma JSM, Singh BN. Electrophysiologic effects of dronedarone (SR33589), a non-iodinated benzofuran derivative on the rabbit heart. Circulation 1999; 100: 2276-81
74. Moss AJ, Schwartz PJ, Crompton RS, et al. The long QT syndrome: a prospective international study. Circulation 1985; 71: 17-21
75. Ryden L, Ariniego R, Arnman K, et al. A double-blind trial of metoprolol in acute myocardial infarction effects on ventricular tachyarrhythmias. N Engl J Med 1983; 308: 614-8
76. Zipes DP. An overview of arrhythmias and antiarrhythmic approaches. J Cardiovasc Electrophysiol 1999; 10: 267-71
77. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation 1992; 85 (Suppl.1 ): 177-91
78. Reiter MJ, Reiffel JA. Importance of beta blockade in the therapy of serious ventricular arrhythmias. Am J Cardiol 1998; 82: 9I-19I
79. Meredith IT, Broughton A, Jennings EL, et al. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med 1991; 325: 618-24
80. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489-99
81. Brugada J, Aguinaga L, Mont L, et al. Coronary artery revasculariszation in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. J Am Coll Cardiol 2001; 37: 529-33
82. Gill JS, Mehta D, Ward DE, et al. Efficacy of flecainide, sotalol and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality. Br Heart J 1992; 68: 392-7
83. De Sutter J, Tavernier R, De Buyzere M, et al. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 2000, 36: 766-72
84. Link MS, Cesarz CA, Griffith JL, et al. Evaluation of coronary revascularization to prevent tachycardia recurrences in survivors of ventricular fibrillation. Am J Cardiol 1999; 83: 960-2
85. The AVID Investigators. A comparison of antiarrhythmic drug therapy with implantable- cardioverter defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337 (22): 1576-83
86. Connolly SJ, Gent M, Roberts RS, et al., for the CIDS Investigators. Canadian Implantable Defibrillator Study (CIDS). A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000; 101: 1297-302
87. Kuck KH, Cappato R, Siebels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The Cardiac Arrest Study (CASH). Circulation 2000; 102: 748-54
88. Farre J, Cabrera JA, Romero J, et al. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator Trial and the Canadian Implantable Defibrillator Study. Am J Cardiol 2000; 86 Suppl. 1: K44-K51
89. Sarter BH, Finkle JK, Gerszten RE, et al. What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction? J Am Coll Cardiol 1996; 28: 122-9
90. Brugada P, Talajic M, Smeets J, et al. The value of the clinical history to assess prognosis of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction. Eur Heart J 1989; 10: 747-52
91. Domanski MJ, Sakseena S, Epstein AE, et al. for the AVID Investigators. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999; 34: 1090-5
92. Sheldon R, Connolly S, Krahn A, et al.. on behalf of the CIDS (Canadian Implantable Defibrillator Study) Investigators. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy. Canadian Implantable Defibrillator Study. Circulation 2000; 101: 1660-4
93. Carusco AC, Marcus FI, Hahn EA, et al. Predictors of arrhythmic death and cardiac arrest in the ESVEM trial. Circulation 1997; 96: 1888-92
94. Bocker D, Block M, Isbruch F, et al. Benefits of treatment with implantable cardioverter- defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 1995; 73: 158-63
95. Raitt MH, Renfroe EG, Epstein AE, et al. for the AVID Investigators. ?Stable? ventricular tachycardia is not a benign rhythm. Insights from the Antiarrhythmics Versus Implantable Defibrillators (AVID) registry. Circulation 2001; 103: 244-52
96. Gregaratos G, Cheitlin MD, Conill A, et al. ACC/AHA Guidelines for implantation of pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/ American Heart Association Task Force on Practice guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998; 31: 1175-209
97. Moss AJ, Zareba W, Hall J, et al. Effectiveness and limitations of â-blocker therapy in congenital long-QT syndrome. Circulation 2000; 101: 616-23
98. Klein LS, Shih HT, Hackett K, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85: 1666-74
99. Coggins DL, Lee RJ, Sweeney J, et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994; 23: 1333-41
100. Nakagawa H, Beckman KJ, McClelland JH, et al. Radiofrequency catheter ablation of idiopathic left ventricular tachycardia guided by a Purkinje potential. Circulation 1993; 88: 2607-17
101. Suchiya T, Okumura K, Honda T, et al. Significance of late diastolic potential preceding purkinje potential in verapamil-sensitive idiopathic left ventricular tachycardia. Circulation 1999; 99: 2408-13
102. Kaltenbrunner W, Cardinal R, Dubuc M, et al. Epicardial and endocardial mapping of ventricular tachycardia in patients with myocardial infarction: is the origin of the tachycardia always subendocardially localized? Circulation 1991; 84: 1058-71
103. Downar E, Kimber S, Harris L, et al. Endocarial mapping of ventricular tachycardia in the intact human heart II. Evidence for multiuse reentry in a function sheet of surviving myocardium. J Am Coll Cardiol 1992; 20: 869-78
104. Rothman SA, Hsia HH, Cossu SF, et al. Radiofrequency catheter ablation of post infarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias. Circulation 1997; 96: 3499-508
105. Morady F, Harvey M, Kalbfleisch SJ, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients with coronary artery disease. Circulation 1993; 87: 363-72
106. Bogun F, Bahu M, Knight BP, et al. Comparison of effective and ineffective target sites that demonstrate concealed entrainment in patients with coronary artery disease undergoing radiofrequency ablation of ventricular tachycardia. Circulation 1997; 95: 183-90
107. El-Shalakany A, Hadjis T, Papageorgion P, et al. Entrainment/mapping criteria for the prediction of termination of ventricular tachycardia by single radiofrequency lesion in patients with coronary artery disease. Circulation 1999; 99: 2283-9
108. Marchlinski FE, Callans DJ, Gottlieb CD, et al. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000; 101: 1288-96
109. Strickberger SA, Knight BP, Michaud GF, et al. Mapping and ablation of ventricular tachycardia guided by virtual electrograms using a noncontact, computerized mapping system. J Am Coll Cardiol 2000; 35: 414-21
110. Greenspon AJ, Hsu SS, Datorre S. Successful radiofrequency catheter ablation of sustained ventricular tachycardial post myocardial infarction in man guided by a multielectrote "basket" catheter. J Cardiovasc Electrophysiol 1997; 8: 565-70
111. Calkins H, Epstein A, Packer D, et al. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter study. Cooled RF Multicenter investigators group. J Am Coll Cardiol 2000; 35: 1905-14
112. Stevenson WG, Friedman PL, Kocovic D, et al. Radiofrequency catheter ablation of ventricular tachycardia after myocardial infarction. Circulation 1998; 98: 308-14
113. Zipes DP. Cardiac Eletrophysiology: promises and contributions. J Am Coll Cardiol 1989; 13: 1329-52
114. Guiraudon G, Fontaine G, Frank R, et al. Endocardial encircling ventriculotomy. A new surgical treatment for life threatening ventricular tachycardia resistant to medical treatment following myocardial infarction. Am Thoracic Surg 1978; 26: 438-44
115. Horowitz LN, Harken AH, Kastor JA, et al. Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med 1980; 302: 589-93
116. Miller JM, Kienzle MG, Harken AH, et al. Resection for ventricular tachycardia: predictors of surgical success. Circulation 1984; 70: 624-31
117. Ostermeyer J, Kirkim JK, Borggrefe M, et al. Electrophysiolocically guided direct operations for maliginant ischemic ventricular tachycardia-results. Thorac Cardiovasc Surg 1989; 37: 20-7
118. Bourke JP, Gray J, Hilton CJ, et al. Identifying patients at low risk of death from cardiac failure after operation for post infarct ventricular tachycardia Ann Thorac Surg 1999; 67: 404-10
119. Miller JM, Gottlieb CD, Hargrove WC, et al. Factors influencing operative mortality in surgery for ventricular tachycardias [abstract]. Circulation 1988; 78: 44